21 May 2018 - Sen. Chuck Grassley said Monday he is in talks with drug companies about a possible deal to pass a drug-pricing bill in exchange for separate action that the companies want.

Grassley, the chairman of the Senate Judiciary Committee, said he is hoping the Senate will soon pass a bill known as the Creates Act, which cracks down on the tactics drug companies use to delay the introduction of cheaper generics.

Grassley told reporters that he is in talks with “Big Pharma” about using the savings from passing that bill to fund other priorities that drug companies want, likely a reference to a separate fix that drug companies have been pushing for to reduce their costs in Medicare.

Read The Hill article